FY2024 · ended May 31, 2024 · Revenue $0, -100.0% YoY · Filed Sep 2, 2025
StimCell Energetics Inc. (STME) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus.
Revenue
$0
-100.0% vs prior year
Net income
$-895,375
-58.1% vs prior year
Operating cash flow (TTM)
$-312,934
-38.0% vs year-ago TTM
Free cash flow
$-450,591
+47.9% vs prior year
EPS
—
Dividend per share
None
Shares outstanding
21.14M
+3.0% vs prior year
Net cash
—
Operating margin
—
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- STME (OTC)
- Fiscal year ends
- May 31
- Incorporated in
- NV
- Headquarters
- Vancouver, British Columbia, Canada
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1493712
- Former names
- Cell MedX Corp. (until Oct 15, 2024); Sports Asylum, Inc. (until Oct 9, 2014); Plandel Resources, Inc. (until Mar 24, 2014)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2026 May 31, 2026 |
FY 2025 May 31, 2025 |
FY 2024 May 31, 2024 |
FY 2023 May 31, 2023 |
FY 2022 May 31, 2022 |
|---|---|---|---|---|---|
| Revenue | — | — | $0 | — | — |
| Net income | -$895,375 | -$566,293 | -$142,486 | -$495,042 | -$697,379 |
| Operating cash flow | -$312,081 | -$141,600 | -$145,898 | -$272,209 | -$450,591 |
| Free cash flow | — | — | — | — | -$450,591 |
| Total assets | $81,454 | $21,222 | $46,122 | $103,270 | $41,344 |
| Total liabilities | $1.9M | $1.3M | $872,577 | $2.5M | $2.1M |
| Stockholders' equity | -$1.8M | -$1.2M | -$826,455 | -$2.4M | -$2.0M |
| Cash and investments | $3,057 | $14,581 | $43,415 | $98,295 | $24,380 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 14, 2026 | Aug 31, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 8, 2026 | Aug 24, 2026 |
| 10-K | Annual report | Aug 31, 2026 | May 31, 2026 |
| 10-Q | Quarterly report | Apr 10, 2026 | Feb 28, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Mar 20, 2026 | Mar 12, 2026 |
| 10-Q | Quarterly report | Jan 15, 2026 | Nov 30, 2025 |
All 273 StimCell Energetics Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.